BBNX

Beta Bionics

26.51 USD
--1.30
4.67%
At close Updated Nov 5, 4:00 PM EST
Pre-market
After hours
26.51
0.00
0%
1 day
-4.67%
5 days
0.65%
1 month
20.77%
3 months
67.68%
6 months
126.97%
Year to date
12.19%
1 year
12.19%
5 years
12.19%
10 years
12.19%
 

About: Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Employees: 409

0
Funds holding %
of 7,509 funds
0
Analysts bullish %
of 4 analysts
0
Positive news %
of 5 articles
Price charts implemented using Lightweight Charts™